Drugs / Sambiloto
Sambiloto
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06520501 | Sep 2024 overdue | — | Universitas Palangka Raya | Not yet recruiting | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sambiloto | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06520501 ↗ |
| Known as | Andrographis Paniculata | “Sambiloto Herbs (Andrographis Paniculata)” NCT06520501 ↗ |
| Known as | Jamu Sambiloto | “Jamu Sambiloto is herbal medicine obtained through products that already have a distribution permit and have a distribution permit registration number, with a consumption dose...” NCT06520501 ↗ |
| Known as | Sambiloto Herbs | “Sambiloto Herbs (Andrographis Paniculata)” NCT06520501 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Jamu Sambiloto is herbal medicine” NCT06520501 ↗ |